has material basis in germline mutation in RET autosomal dominant disease malignant urinary system neoplasm multiple endocrine neoplasia type 2B https://github.com/monarch-initiative/mondo/issues/4521 https://github.com/monarch-initiative/mondo/issues/9178 https://rarediseases.info.nih.gov/diseases/10225/multiple-endocrine-neoplasia-type-2b https://www.malacards.org/card/multiple_endocrine_neoplasia_type_iib icd11.foundation:1754393919 multiple endocrine neoplasia, type III OMIM:162300 MESH:D018814 multiple endocrine adenomatosis type IIB MEN2B men IIB Orphanet:247709 ICD9:258.03 multiple endocrine neoplasia IIB multiple endocrine neoplasia type 2B DOID:10016 An autosomal dominant disorder caused by specific pathogenic variants in the RET gene, characterized by an increased risk of very early onset medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism, and mucosal neuromas. SCTID:61530001 RET-related multiple endocrine neoplasia type 2B ICD9:237.4 Neuromata, mucosal, with endocrine tumours MEDGEN:9959 MedDRA:10056420 NANDO:2201053 MONDO:0008082 men 2B NCIT:C3227 multiple endocrine neoplasia type III multiple endocrine neoplasia, type 3 (formerly) multiple endocrine neoplasia type 3 men type 2B men type IIB Wagenmann-Froboese syndrome multiple endocrine neoplasia, type IIB multiple endocrine neoplasia type IIB GARD:0010225 UMLS:C0025269 multiple endocrine neoplasia type 2